Affiliation:
1. *Cancer Research Campaign Institute for Cancer Studies and
2. †Department of Rheumatology, The Medical School, University of Birmingham, Edgbaston, Birmingham, United Kingdom
Abstract
AbstractTCR usage has been studied in a panel of Th cell clones specific for the same peptide epitope (P N S Q D R G R P R R S D), derived from the human papillomavirus type 1 (HPV1) E4 protein, and restricted through HLA-DQ8. After identifying the V, D, and J genes used by the TCRs and sequencing across the V(D)J junctions, five different α-chain sequences and five different β-chain sequences, comprising six independent clones, were identified. A structural model of our E4 peptide/HLA-DQ8 complex predicted that the guanidinyl side chain on the arginine residue at position 6 of the peptide could exist in different orientations. An intramolecular interaction between this arginine and the glutamine residue at position four appeared to control this orientation. Interacting HPV1 E4-specific TCRs would therefore have to recognize the complex in different conformations, and molecular modeling of the TCRs suggested that this could be achieved by changing the dimensions of the central pocket formed where the CDR3 loops of the TCR α- and β-chains converge. It is known that interactions between bound peptide and amino acid residues lining the peptide-binding cleft of HLA molecules are important for determining the conformation and orientation of the peptide/MHC complex. The suggestion here that intramolecular interactions between amino acids of close proximity on the bound peptide are also important adds a further level of complexity to the mechanism by which TCRs interact with Ag.
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference84 articles.
1. zur Hausen, H.. 1991. Human papillomavirus in the pathogenesis of anogenital cancer. Virology 184: 9
2. Bosch, F. X., M. M. Manos, N. Hunoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah. 1995. Prevalence of human papillomavirus in cervical carcinoma: a worldwide perspective (International biological study on cervical cancer (IBSCC) Study Group). J. Natl. Cancer Inst. 87: 796
3. Chua, K. L., A. Hjierpa. 1996. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer 77: 121
4. Doorbar, J., D. Campbell, R. J. A. Grand, P. H. Gallimore. 1986. Identification of the human papillomavirus-1a E4 gene products. EMBO J. 5: 355
5. Breitburd, F., O. Croissant, G. Orth. 1987. Expression of human papillomavirus type 1 E4 gene products in warts. B. M. Steinberg, and J. L. Brandsma, and L. B. Taichman, eds. In Papillomaviruses: Cancer Cells Vol. 5: 115 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.